Prosecution Insights
Last updated: October 04, 2026

Nucleix Ltd.

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems

4 pending office actions • 3 art units • 3 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Nucleix Ltd. has 4 pending office actions within the Transportation, E-Commerce & Mechanical Systems technology area. These actions are distributed across 3 distinct art units, showing a relatively tight technical focus for the current workload. Despite the small number of actions, the spread across 3 art units indicates that the company's technology is being evaluated under several different classification systems.

The portfolio is handled by 3 distinct examiners. KIM, YOUNG J is the busiest examiner, responsible for 2 of the pending actions. This means one examiner is managing a large portion of the company's current pending office actions, while the other 2 actions are split between 2 other examiners. This concentration with KIM, YOUNG J makes that examiner's individual preferences particularly important for the company's immediate prosecution success.

With 4 pending actions and 3 examiners, the portfolio shows a high degree of examiner concentration for its size. The fact that KIM, YOUNG J handles 2 of the 4 actions suggests that a significant portion of the company's current patent office interactions are focused on a single individual. Practitioners should prioritize understanding the specific tendencies of this examiner given their share of the pending workload.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (50%)
1
Medium (25%)
1
Easy (25%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (25%)
§103 only1 (25%)
Double-patenting only1 (25%)
Multi-statute (no §101)1 (25%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
25% of docket
1
Business / Other
25% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, YOUNG J 2 64.8% +18.1%
PATEL, JAY M 1 64.6% +39.2%
BRAZIN, JACQUELINE 1 66.0% +52.7%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES KIM, YOUNG J 13d
18711585 WHOLE GENOME CPG ANALYSIS KIM, YOUNG J —

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES KIM, YOUNG J 13d
17780227 SYSTEMS AND DEVICES FOR SAMPLE PREPARATION AND ANALYTE DETECTION BRAZIN, JACQUELINE 55d
19274214 DEEP LEARNING-BASED METHODS, DEVICES, AND SYSTEMS FOR PRENATAL TESTING PATEL, JAY M —
18711585 WHOLE GENOME CPG ANALYSIS KIM, YOUNG J —

Top Art Units

Art UnitApps
3681 1
1681 1
1798 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19274214 DEEP LEARNING-BASED METHODS, DEVICES, AND SYSTEMS FOR PRENATAL TESTING PATEL, JAY M 3681 DP Non-Final OA — Pending Jul 18, 2025
18711585 WHOLE GENOME CPG ANALYSIS KIM, YOUNG J — §103§112 Non-Final OA — Pending May 18, 2024
18261995 NON-INVASIVE CANCER DETECTION BASED ON DNA METHYLATION CHANGES KIM, YOUNG J 1681 §101§103§112 Final Rejection 13d Pending Jul 18, 2023
17780227 SYSTEMS AND DEVICES FOR SAMPLE PREPARATION AND ANALYTE DETECTION BRAZIN, JACQUELINE 1798 §103 Final Rejection 55d Pending May 26, 2022

Managing Nucleix Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month